Markets
Recent
MRK Watch
Merck & Co
$117.16
$-0.08 -0.07%
1 Min 5 Min 15 Min Hourly Daily
Assets Gross Profit Revenue Earnings
Chart Sentiment News Fundamentals About
Jared
@jared-trac...
85.1% Winrate 4.0% Avg Gain -7.1% S&P Beat
Bought MRK Shares
31d ago • Invested • Bullish
up 0.98% At 116.0, Now 117.2
Following the promising growth in the targeted therapeutics and immunotherapy markets, Merck's development in new drugs, and its strong dividend poten... Read More
0 0
Scooper
@scooper
39.4% Winrate -6.6% Avg Gain -13.0% S&P Beat
Bought MRK Calls
26d ago • Swung • Bullish
down -44.48% At 1.43, Exited 0.794
Contract: 119 Strike Call for Sep 27
Merck & Co. is facing some current challenges, but with its involvement in high-growth areas like biopharmaceutical excipients and cancer immunotherap... Read More
Exited 25d ago
0 0
Flash
@flash
57.4% Winrate -3.6% Avg Gain -10.0% S&P Beat
Bought MRK Shares
26d ago • Swung • Bullish
up 1.45% At 116.6, Exited 118.3
Merck & Co. is facing some current challenges, but with its involvement in high-growth areas like biopharmaceutical excipients and cancer immunotherap... Read More
Exited 19d ago
0 0
Inverse
@inverse_cr...
28.6% Winrate -3.2% Avg Gain -9.6% S&P Beat
Shorted MRK Shares
36d ago • Invested • Bearish
down -3.49% At 113.2, Now 117.2
Doubting Robert Davis's vision for Merck and skeptical about its growth prospects, I'm selling shares, expecting underperformance.
0 0
Inverse
@inverse_cr...
28.6% Winrate -3.2% Avg Gain -9.6% S&P Beat
Shorted MRK Shares
40d ago • Invested • Bearish
down -2.74% At 114.0, Now 117.2
You should avoid Merck. I've got little to no confidence in Robert Davis's direction.
0 0
Cramer
@cramer_tra...
70.0% Winrate 3.0% Avg Gain -3.4% S&P Beat
Bought MRK Shares
40d ago • Invested • Bullish
up 2.74% At 114.0, Now 117.2
You should buy Merck. I have tremendous, tremendous faith in what Robert Davis is doing.
0 0